Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS)
CNY 23.7
(2.86%)
CNY 23.7
(2.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.07 Billion | 1.01 Billion | 917.03 Million | 752.5 Million | 641.17 Million | 486.24 Million |
| Net Income | 708.29 Million | 644.21 Million | 530.94 Million | 490.32 Million | 479.43 Million | 470.23 Million |
| Depreciation & Amortization | 122.29 Million | 121.94 Million | 115.44 Million | 112.76 Million | 112.97 Million | 72.54 Million |
| Deferred income taxes | -13.14 Million | -673.79 Thousand | -6.18 Million | -9.58 Million | -824.31 Thousand | 1.23 Million |
| Stock-based compensation | 8.94 Million | 10.66 Million | 1.19 Million | - | - | - |
| Change in working capital | 161.49 Million | 312.42 Million | 330.19 Million | 131.65 Million | 77.33 Million | -41.29 Million |
| Other non-cash items | 181.97 Million | -72.58 Million | -59.54 Million | 17.75 Million | -28.56 Million | -15.24 Million |
| Investing Cash Flow | -182.43 Million | 79.42 Million | -1.23 Billion | -658.79 Million | -511.48 Million | -61.48 Million |
| Investments in PPE | -208.87 Million | -345.64 Million | -188.49 Million | -182.53 Million | -76.33 Million | -121.37 Million |
| Acquisitions | -13.23 Million | 52.34 Thousand | 1.24 Million | 183.19 Million | 131.2 Million | 719.37 Thousand |
| Investment purchases | -1.84 Billion | -3.26 Billion | -5.19 Billion | -3.45 Billion | -2.69 Billion | -13.5 Million |
| Sales/Maturities of investments | 1.88 Billion | 3.68 Billion | 3.94 Billion | 2.98 Billion | 2.12 Billion | 72.71 Million |
| Other Investing Activities | 81.84 Million | 0.53 | 197.89 Million | -182.53 Million | 76.56 Thousand | -40.49 Thousand |
| Financing Cash Flow | -803.57 Million | -733.69 Million | -349.48 Million | -163.38 Million | -217 Million | -135 Million |
| Debt repayment | -1.94 Million | -30 Million | -801.94 Thousand | - | -70 Million | - |
| Dividends payments | -792.7 Million | -724.01 Million | -308.7 Million | -163.38 Million | -147 Million | -135 Million |
| Common Stock Repurchased | -1.12 Million | -2.31 Million | -73.27 Million | - | - | - |
| Common Stock Issuance | - | 2.31 Million | 74.07 Million | - | - | - |
| Other Financing Activities | -9.74 Million | 29.4 Million | -36.11 Million | -5.88 Million | -70 Million | - |
| Accounts receivables | 291.45 Million | 27.39 Million | 159.5 Million | 240.59 Million | 42.56 Million | -109.7 Million |
| Accounts payables | -101.83 Million | 290.04 Million | 200.5 Million | -92.81 Million | 33.69 Million | 48.67 Million |
| Inventory | -28.12 Million | -4.34 Million | -23.62 Million | -6.54 Million | 1.9 Million | 18.51 Million |
| Other working capital | -1.00 | -673.79 Thousand | -6.18 Million | -9.58 Million | -824.31 Thousand | -59.8 Million |
| Cash at beginning of period | 1.37 Billion | 188.6 Million | 857.62 Million | 927.29 Million | 1.01 Billion | 724.84 Million |
| Cash at end of period | 1.33 Billion | 550.32 Million | 188.6 Million | 857.62 Million | 927.29 Million | 1.01 Billion |
| Capital Expenditure | -208.87 Million | -345.64 Million | -188.49 Million | -182.53 Million | -76.33 Million | -121.37 Million |
| Effect of forex changes on cash | -130.2 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -38.39 Million | 361.71 Million | -669.01 Million | -69.67 Million | -87.3 Million | 289.76 Million |
| Free Cash Flow | 868.94 Million | 670.34 Million | 728.54 Million | 569.96 Million | 564.84 Million | 364.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 145.58 Million | 221.97 Million | 266.77 Million | 708.29 Million | 118.81 Million | 142.47 Million |
| Depreciation & Amortization | - | 32.58 Million | 32.58 Million | 122.29 Million | 30.93 Million | -59.04 Million |
| Deferred income taxes | -1.65 Million | - | - | -13.14 Million | -281.21 Million | 236.07 Million |
| Stock-based compensation | - | 23.3 Million | - | 8.94 Million | 8.94 Million | -4.61 Million |
| Change in working capital | - | -565.3 Million | - | 161.49 Million | 272.27 Million | -172.41 Million |
| Other non-cash items | -148.23 Million | 227.25 Million | -184.19 Million | 181.97 Million | 319.3 Million | -78.28 Million |
| Investing Cash Flow | -221.34 Million | 185.65 Million | -67.26 Million | -182.43 Million | 373.46 Million | -560.44 Million |
| Investments in PPE | -57.85 Million | -34.75 Million | -55.46 Million | -208.87 Million | -55.72 Million | -57.08 Million |
| Acquisitions | -956.42 Thousand | 102.04 Thousand | 11.79 Thousand | -13.23 Million | -13.23 Million | 3380.52 |
| Investment purchases | -456.31 Million | -124.68 Million | -360 Million | -1.84 Billion | 158.27 Million | -873.88 Million |
| Sales/Maturities of investments | 293.78 Million | 345 Million | 348.18 Million | 1.88 Billion | 284.15 Million | 370.52 Million |
| Other Investing Activities | -956.42 Thousand | 243.74 Million | -11.8 Million | 81.84 Million | 446.78 Million | 0.90 |
| Financing Cash Flow | -901.66 Thousand | -446.63 Million | -550.73 Thousand | -803.57 Million | -384.85 Million | -7.68 Million |
| Debt repayment | - | - | - | -1.94 Million | - | - |
| Dividends payments | -706.01 Thousand | -440.39 Million | - | -792.7 Million | -384.11 Million | -7.25 Million |
| Common Stock Repurchased | 954.77 Thousand | -954.77 Thousand | - | -1.12 Million | -1.12 Million | 720.97 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -195.64 Thousand | -4.54 Million | -550.73 Thousand | -9.74 Million | 372.74 Thousand | -1.15 Million |
| Accounts receivables | - | -566.6 Million | - | 291.45 Million | 291.45 Million | -159.25 Million |
| Accounts payables | - | - | - | -101.83 Million | - | 4.61 Million |
| Inventory | - | 78.26 Thousand | - | -28.12 Million | -28.12 Million | -13.15 Million |
| Other working capital | - | 1.22 Million | - | -1.00 | 8.94 Million | -4.61 Million |
| Cash at beginning of period | 812.58 Million | 1.33 Billion | 642.14 Million | 1.37 Billion | 2.56 Billion | 711.95 Million |
| Cash at end of period | 557.4 Million | 1.14 Billion | 656.91 Million | 1.33 Billion | 1.33 Billion | 184.48 Million |
| Capital Expenditure | -57.85 Million | -34.75 Million | -55.46 Million | -208.87 Million | -55.72 Million | -57.08 Million |
| Effect of forex changes on cash | - | - | - | -130.2 Million | -1.69 Billion | -23.52 Million |
| Net cash flow / Change in cash | -255.18 Million | -191.63 Million | 14.77 Million | -38.39 Million | -1.23 Billion | -527.46 Million |
| Free Cash Flow | -62.15 Million | 381.88 Million | 27.12 Million | 868.94 Million | 413.32 Million | 7.09 Million |
7068
CP
STAR
ADFFOODS
STOR-B
HYLN